| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
134,746,000 |
| Market
Cap: |
2.09(B) |
| Last
Volume: |
3,983,089 |
Avg
Vol: |
3,954,359 |
| 52
Week Range: |
$9.36 - $15.72 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 754 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
3,800 |
3,800 |
3,800 |
| Total Buy Value |
$0 |
$41,116 |
$41,116 |
$41,116 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
144,000 |
2,209,137 |
2,255,921 |
2,280,062 |
| Total Sell Value |
$2,247,660 |
$24,599,258 |
$25,261,124 |
$25,566,573 |
| Total People Sold |
1 |
2 |
2 |
4 |
| Total Sell Transactions |
2 |
4 |
6 |
8 |
| End Date |
2025-11-13 |
2025-08-12 |
2025-02-11 |
2024-02-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kroin David |
|
– – • |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,726,349) |
0 |
|
- |
|
| Sun Elaine D |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(29,865) |
0 |
|
- |
|
| Kisner Daniel L |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(21,829) |
0 |
|
- |
|
| Kisner Daniel L |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,500) |
0 |
|
- |
|
| Spencer Ryan |
CEO and Director |
• • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(301,000) |
0 |
|
- |
|
| Spencer Ryan |
CEO and Director |
• • – |
2026-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
301,000 |
136,000 |
|
- |
|
| Spencer Ryan |
CEO and Director |
• • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(379,620) |
0 |
|
- |
|
| Cano Francis |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,663) |
0 |
|
- |
|
| Myers Scott Dunseth |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(31,204) |
0 |
|
- |
|
| Myers Scott Dunseth |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,800) |
0 |
|
- |
|
| Emini Emilio |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,075) |
0 |
|
- |
|
| Silvernail Lauren P |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,075) |
0 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(124,224) |
0 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2026-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
124,224 |
56,364 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(63,334) |
0 |
|
- |
|
| Macgregor Brent |
|
– • – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(21,829) |
0 |
|
- |
|
| Macdonald Kelly |
SVP and CFO |
• – – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(88,854) |
0 |
|
- |
|
| Macdonald Kelly |
SVP and CFO |
• – – |
2026-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
88,854 |
42,424 |
|
- |
|
| Macdonald Kelly |
SVP and CFO |
• – – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(60,204) |
0 |
|
- |
|
| Slebir John L |
SVP General Counsel |
• – – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(92,424) |
0 |
|
- |
|
| Slebir John L |
SVP General Counsel |
• – – |
2026-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
92,424 |
42,424 |
|
- |
|
| Slebir John L |
SVP General Counsel |
• – – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(69,634) |
0 |
|
- |
|
| Metzinger Joseph Anthony |
VP, Chief Accounting Officer |
• – – |
2026-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,129) |
0 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2026-01-15 |
4 |
AS |
$15.64 |
$1,782,960 |
D/D |
(114,000) |
63,344 |
|
-1% |
|
| Novack David F |
President & COO |
• – – |
2026-01-15 |
4 |
OE |
$6.81 |
$1,120,280 |
D/D |
114,000 |
177,344 |
|
- |
|
368 Records found
|
|
Page 1 of 15 |
|
|
